Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMYMP) Short-Term Debt issuances (2016 - 2025)

Historic Short-Term Debt issuances for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to -$406.0 million.

  • Bristol Myers Squibb's Short-Term Debt issuances fell 322307.69% to -$406.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $25.0 million, marking a year-over-year decrease of 9916.67%. This contributed to the annual value of $25.0 million for FY2025, which is 9916.67% down from last year.
  • Bristol Myers Squibb's Short-Term Debt issuances amounted to -$406.0 million in Q4 2025, which was down 322307.69% from $5.0 million recorded in Q3 2025.
  • Bristol Myers Squibb's Short-Term Debt issuances' 5-year high stood at $3.0 billion during Q1 2024, with a 5-year trough of -$406.0 million in Q4 2025.
  • In the last 5 years, Bristol Myers Squibb's Short-Term Debt issuances had a median value of $27.5 million in 2022 and averaged $163.3 million.
  • Its Short-Term Debt issuances has fluctuated over the past 5 years, first crashed by 370000.0% in 2021, then skyrocketed by 223359.38% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Short-Term Debt issuances stood at -$114.0 million in 2021, then surged by 219.3% to $136.0 million in 2022, then crashed by 359.56% to -$353.0 million in 2023, then skyrocketed by 103.68% to $13.0 million in 2024, then tumbled by 3223.08% to -$406.0 million in 2025.
  • Its last three reported values are -$406.0 million in Q4 2025, $5.0 million for Q3 2025, and $58.0 million during Q2 2025.